Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional‐based study
- 20 October 2010
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 223 (3), 327-335
- https://doi.org/10.1002/path.2816
Abstract
A variety of analyses, including fluorescence in situ hybridization (FISH), quantitative PCR (qPCR) and array CGH (aCGH), have been performed on a series of chordomas from 181 patients. Twelve of 181 (7%) tumours displayed amplification of the T locus and an additional two cases showed focal amplification; 70/181 (39%) tumours were polysomic for chromosome 6, and 8/181 (4.5%) primary tumours showed a minor allelic gain of T as assessed by FISH. No germline alteration of the T locus was identified in non-neoplastic tissue from 40 patients. Copy number gain of T was seen in a similar percentage of sacrococcygeal, mobile spine and base of skull tumours. Knockdown of T in the cell line, U-CH1, which showed polysomy of chromosome 6 involving 6q27, resulted in a marked decrease in cell proliferation and morphological features consistent with a senescence-like phenotype. The U-CH1 cell line was validated as representing chordoma by the generation of xenografts, which showed typical chordoma morphology and immunohistochemistry in the NOD/SCID/interleukin 2 receptor [IL2r] mouse model. In conclusion, chromosomal aberrations resulting in gain of the T locus are common in sporadic chordomas and expression of this gene is critical for proliferation of chordoma cells in vitro. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.This publication has 30 references indexed in Scilit:
- T (brachyury) gene duplication confers major susceptibility to familial chordomaNature Genetics, 2009
- Modeling the molecular consequences of unbalanced translocations in cancer: Lessons from acute lymphoblastic leukemiaCell Cycle, 2009
- Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayBritish Journal of Cancer, 2009
- Impact of cytogenetic abnormalities on the management of skull base chordomasJournal of Neurosurgery, 2009
- Making a commitment: cell lineage allocation and axis patterning in the early mouse embryoNature Reviews Molecular Cell Biology, 2009
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- Update on the Cytogenetics and Molecular Genetics of ChordomaHereditary Cancer in Clinical Practice, 2005
- First cytogenetic study of a recurrent familial chordoma of the clivusInternational Journal of Cancer, 1999
- Mesoderm formation in response to Brachyury requires FGF signallingCurrent Biology, 1995